医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Avery Dennison Relaunches Its Medical Solutions Group as Vancive Medical Technologies

2012年11月13日 PM07:25
このエントリーをはてなブックマークに追加

Smart Multimedia Gallery

 

Colleen Ward, vice president of marketing, Vancive Medical Technologies (Photo: Business Wire)Colleen Ward, vice president of marketing, Vancive Medical Technologies (Photo: Business Wire)

View and Share Photo

Close Window


Howard Kelly, vice president and general manager of Vancive Medical Technologies (Photo: Business Wire)Howard Kelly, vice president and general manager of Vancive Medical Technologies (Photo: Business Wire)

View and Share Photo

Close Window


CHICAGO

Avery Dennison Corporation (NYSE:AVY) has renamed and repositioned its medical solutions group as Vancive Medical Technologies™. The new name replaces Avery Dennison Medical Solutions and emphasizes the company’s renewed focus on creating intuitive, cost-efficient products that help improve the quality and outcomes of healthcare.

Howard Kelly, vice president and general manager of Vancive Medical Technologies (Photo: Business Wi ...

Howard Kelly, vice president and general manager of Vancive Medical Technologies (Photo: Business Wire)

“The new brand reflects the evolution of our business and the role we intend to play in the future of healthcare innovation,” says vice president and general manager of Vancive Medical Technologies Howard Kelly.

“Over the past three years, we have brought an unprecedented level of initiative and ingenuity to the medical device marketplace, allowing us to extend beyond our traditional products. The Vancive name demonstrates our commitment to continue developing technologies and solutions that make healthcare easier and more accessible for care providers and their patients.”

“Our latest innovations are excellent examples of our vision for the business,” says Colleen Ward, vice president of marketing, Vancive Medical Technologies. “Our new personalized monitoring system, Metria™, empowers patients and physicians to make smarter health decisions concerning physical fitness or chronic health conditions. Intelishield™, our barrier film solution, enables ostomy patients to maintain their quality of life, providing enhanced odor barrier function while addressing environmental and health concerns through the elimination of DEHP and PVC in the film. And BeneHold™, through its range of unique solutions for securement and wound dressing, helps care providers do their jobs more efficiently.”

“We are excited about the impact Vancive will make on the next generation of medical technologies,” Kelly says. “Powered by advanced adhesive and material innovations and a deep understanding of our users’ needs, Vancive will deliver products that fit seamlessly into people’s lives and work, so we can continue to take steps toward a more productive and proactive future of healthcare.”

To learn more about Vancive Medical Technologies and how they are changing the way people think about and interact with healthcare, visit vancive.averydennison.com.

About Vancive Medical Technologies

Vancive Medical Technologies makes inspired advances that lead to intelligent results. The business uses the most advanced adhesive and material technologies to create products that make healthcare easier for everyone. Vancive Medical Technologies is an Avery Dennison business headquartered in Chicago, Illinois. For more information, visit vancive.averydennison.com.

About Avery Dennison

Avery Dennison (NYSE:AVY) is a global leader in labeling and packaging materials and solutions. The company’s applications and technologies are an integral part of products used in every major market and industry. With operations in more than 50 countries and 30,000 employees worldwide, Avery Dennison serves customers with insights and innovations that help make brands more inspiring and the world more intelligent. Headquartered in Pasadena, California, the company reported sales from continuing operations of $6 billion in 2011. Learn more at www.averydennison.com.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50470578&lang=en

CONTACT

Avery Dennison Corporation
Media Relations Contact
Bob
Giuliano, +610-328-1051
Bob.Giuliano@prplace.biz
or
Business
Contact

Colleen Ward, +32 475 35 11 23
Colleen.ward@eu.averydennison.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • BioVectra与Keryx Biopharmaceuticals签署枸橼酸铁扩产协议
  • Eternity Healthcare Inc. Enters into Share Exchange Agreement with Guizho Tongren Healthy China Biotechnology Co. Ltd.
  • Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
  • Chi-Med Initiates Fruquintinib U.S. Clinical Trials
  • Orthocell Granted European Tendon Regeneration Patent